{"url_path":"/sec/rxst/8-k/2026-07-15/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1111485/0001193125-26-304812-index.html","accession_number":"0001193125-26-304812","cik":"0001111485","ticker":"RXST","issuer_name":"RxSight, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1111485/0001193125-26-304812-index.html","primary_entity_key":"0001111485","primary_entity_name":"RxSight, Inc."},"word_count":78,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n\nNumber\n\n  \n\nDescription\n\n99.1\n  \n[Press Release, dated July 15, 2026](d140030dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nRxSight, Inc.\n\nDate: July 15, 2026\n \n\n \nBy:\n \n\n/s/ Mark Wilterding\n\n \n\n \nName:\n \nMark Wilterding\n\n \n\n \nTitle:\n \nChief Financial Officer"}